🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will assess the pharmacokinetics (PK), pharmacodynamics (PD) and...
Status
Completed
Location
Clinical Research of West Florida Inc - Clearwater
Start Date
2025-10-06
Trial ID
NCT07132983
The purpose of this study is to assess the rate and extent of absorption of...
Status
Completed
Location
Clinical Pharmacology Unit
Start Date
2017-02-06
Trial ID
NCT03010059
Treatments Being Tested
The primary objective is to evaluate in a double-blinded (neither physician...
Status
Completed
Location
Multiple Locations
Start Date
2015-03-04
Trial ID
NCT02426632
A single center, double-blind, randomized, dose-escalation study to assess ...
Status
Completed
Location
Taipei Medical University
Start Date
2019-03-26
Trial ID
NCT04088721
Treatments Being Tested
A substance called immunoglobulin E (IgE), which is naturally produced by o...
Status
Completed
Location
Alabama Allergy and Asthma Center
Start Date
2004-04
Trial ID
NCT00079937
Treatments Being Tested
The purpose of this study is to evaluate in a double-blinded fashion the ta...
Status
Completed
Location
Multiple Locations
Start Date
2016-06
Trial ID
NCT02813460
Treatments Being Tested
The purpose of this study is to estimate the relative bioavailability of ni...
Status
Completed
Location
New Haven Clinical Research Unit
Start Date
2022-08-31
Trial ID
NCT05525910
Study in healthy males to assess bioavailability of 4 different fostamatini...
Status
Completed
Location
Research Site
Start Date
2011-08
Trial ID
NCT01387308
Treatments Being Tested
Title: The Efficacy, Safety, and PK/PD of Efgartigimod Followed by Telitaci...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-02
Trial ID
NCT06827587
This is an open-label, dose-titration trial to study the efficacy, safety, ...
Status
Completed
Location
National Institute of Allergy and Infectious Disease (NIAID)
Start Date
2016-09-27
Trial ID
NCT02629419
Treatments Being Tested